GKOS · GLAUKOS Corp · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-28 | Navratil Tomas |
CHIEF DEVELOPMENT OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
Includes 38,817 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
Common Stock
|
10 |
| 2026-08-28 | Navratil Tomas |
CHIEF DEVELOPMENT OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $179.69 to $180.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Includes 38,817 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
Common Stock
|
7,643 |
| 2026-08-28 | Navratil Tomas |
CHIEF DEVELOPMENT OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $180.71 to $181.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Includes 38,817 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
Common Stock
|
6,091 |
| 2026-08-19 | Kliman Gilbert H |
Insider |
Convert↓
|
Stock Option (Right to Buy)
|
2,500 |
| 2026-08-19 | Kliman Gilbert H |
Insider |
Sell↓
Filing footnotes — Common Stock (Direct)
Includes 2,501 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. |
Common Stock
|
2,500 |
| 2026-08-19 | Kliman Gilbert H |
Insider |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes 2,501 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. |
Common Stock
|
2,500 |
| 2026-08-11 | Gilliam Joseph E |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
Common Stock
|
10,000 |
| 2026-08-11 | Gilliam Joseph E |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. |
Stock Option (Right to Buy)
|
20,000 |
| 2026-08-11 | Gilliam Joseph E |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years. |
Stock Option (Right to Buy)
|
10,000 |
| 2026-08-11 | Gilliam Joseph E |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $178.60 to $179.58). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
Common Stock
|
27,963 |
| 2026-08-11 | Gilliam Joseph E |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. Total amount reported has been adjusted to correct a typographical error made in a Form 4 report filed by the Reporting Person on March 17, 2025, in which 13,721 stock options earned were erroneously reported as 13,271 stock options. |
Stock Option (Right to Buy)
|
20,000 |
| 2026-08-11 | Gilliam Joseph E |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
Common Stock
|
10,000 |
| 2026-08-11 | Gilliam Joseph E |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
Common Stock
|
20,000 |
| 2026-08-11 | Gilliam Joseph E |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $179.68 to $180.60). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
Common Stock
|
32,037 |
| 2026-08-11 | Gilliam Joseph E |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 22, 2023, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. |
Stock Option (Right to Buy)
|
10,000 |
| 2026-08-11 | Gilliam Joseph E |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
Common Stock
|
20,000 |
| 2026-08-07 | Thurman Alex R. |
SVP & CHIEF FINANCIAL OFFICER |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
Common Stock
|
20,000 |
| 2026-08-07 | Thurman Alex R. |
SVP & CHIEF FINANCIAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. This transaction was executed in multiple trades at prices ranging from $180.00 to $180.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
Common Stock
|
20,000 |
| 2026-08-07 | Thurman Alex R. |
SVP & CHIEF FINANCIAL OFFICER |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years. |
Stock Option (Right to Buy)
|
20,000 |
| 2026-07-31 | WEN LEANA |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Includes 2,501 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. |
Common Stock
|
525 |
| 2026-07-16 | Thurman Alex R. |
SVP & CHIEF FINANCIAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
Common Stock
|
10,000 |
| 2026-07-16 | Thurman Alex R. |
SVP & CHIEF FINANCIAL OFFICER |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
Common Stock
|
10,000 |
| 2026-07-16 | Thurman Alex R. |
SVP & CHIEF FINANCIAL OFFICER |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years. |
Stock Option (Right to Buy)
|
10,000 |
| 2026-07-09 | Thurman Alex R. |
SVP & CHIEF FINANCIAL OFFICER |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years. |
Stock Option (Right to Buy)
|
10,000 |
| 2026-07-09 | Thurman Alex R. |
SVP & CHIEF FINANCIAL OFFICER |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
Common Stock
|
10,000 |
| 2026-07-09 | Thurman Alex R. |
SVP & CHIEF FINANCIAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
Common Stock
|
10,000 |
| 2026-07-06 | Thurman Alex R. |
SVP & CHIEF FINANCIAL OFFICER |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
Common Stock
|
10,000 |
| 2026-07-06 | Thurman Alex R. |
SVP & CHIEF FINANCIAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
Common Stock
|
10,000 |
| 2026-07-06 | Thurman Alex R. |
SVP & CHIEF FINANCIAL OFFICER |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025. These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years. |
Stock Option (Right to Buy)
|
10,000 |
| 2026-07-01 | Navratil Tomas |
CHIEF DEVELOPMENT OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. Includes 38,817 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
Common Stock
|
716 |
| 2026-06-25 | Burns Thomas William |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 18, 2021 Includes 56,382 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
Common Stock
|
4,059 |
| 2026-06-25 | Gilliam Joseph E |
Director |
Tax↓
Filing footnotes — Common Stock (Direct)
Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 18, 2021. Includes 41,983 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
Common Stock
|
1,056 |
| 2026-06-25 | Navratil Tomas |
CHIEF DEVELOPMENT OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 18, 2021. Includes 38,817 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
Common Stock
|
483 |
| 2026-06-16 | Navratil Tomas |
CHIEF DEVELOPMENT OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. Includes 39,791 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
Common Stock
|
1,537 |
| 2026-05-28 | Stapley Marc |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above. Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date. |
Stock Option (Right to Buy)
|
2,987 |
| 2026-05-28 | WEISNER AIMEE S |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above. Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date. |
Stock Option (Right to Buy)
|
2,987 |
| 2026-05-28 | WEN LEANA |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above. Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date. |
Stock Option (Right to Buy)
|
2,987 |
| 2026-05-28 | Kliman Gilbert H |
Insider |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above. Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date. |
Stock Option (Right to Buy)
|
2,987 |
| 2026-05-28 | Hoffmeister David F |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above. Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date. |
Stock Option (Right to Buy)
|
2,987 |
| 2026-05-28 | Torres Denice |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above. Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date. |
Stock Option (Right to Buy)
|
2,987 |
| 2026-05-28 | Foley Mark J |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above. Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date. |
Stock Option (Right to Buy)
|
2,987 |
| 2026-05-26 | Hoffmeister David F |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This option was granted on June 2, 2016 and fully vested on the first anniversary of the grant date. |
Stock Option (Right to Buy)
|
15,000 |
| 2026-05-26 | Hoffmeister David F |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes 2,861 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. |
Common Stock
|
15,000 |
| 2026-05-14 | Kliman Gilbert H |
Insider |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This option was granted on June 2, 2016 and fully vested on the first anniversary of the grant date. |
Stock Option (Right to Buy)
|
5,000 |
| 2026-05-14 | Kliman Gilbert H |
Insider |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes 2,731 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. |
Common Stock
|
5,000 |
| 2026-05-14 | Kliman Gilbert H |
Insider |
Sell↓
Filing footnotes — Common Stock (Direct)
Includes 2,731 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. |
Common Stock
|
5,000 |
| 2026-05-11 | Kliman Gilbert H |
Insider |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes 2,731 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. |
Common Stock
|
5,000 |
| 2026-05-11 | Kliman Gilbert H |
Insider |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This option was granted on June 2, 2016 and fully vested on the first anniversary of the grant date. |
Stock Option (Right to Buy)
|
5,000 |
| 2026-05-11 | Kliman Gilbert H |
Insider |
Sell↓
Filing footnotes — Common Stock (Direct)
Includes 2,731 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. |
Common Stock
|
5,000 |
| 2026-05-01 | WEN LEANA |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Includes 2,731 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. |
Common Stock
|
1,700 |